<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02939339</url>
  </required_header>
  <id_info>
    <org_study_id>00042165</org_study_id>
    <nct_id>NCT02939339</nct_id>
  </id_info>
  <brief_title>Theta Burst TMS as a Tool to Change Smoking Behavior</brief_title>
  <official_title>Theta Burst TMS as a Tool to Change Smoking Behavior</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine whether transcranial magnetic stimulation (TMS) is an
      effective treatment in decreasing craving in individuals who habitually smoke cigarettes. The
      study consists of six total visits to MUSC; one for the consent process, two that will
      include MRI scans, and five that will include TMS administration. Compensation will be
      provided for each visit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior and recent evidence suggests a role of medial prefrontal cortex (mPFC) in cigarette
      smoking. The present study will examine whether a five-day regimen of theta-burst
      transcranial magnetic stimulation (TMS) reduces cigarette smoking outside of the lab
      (examined through self-report and physiological measures) and motivation to smoke inside the
      lab (examined through behavioral tasks and functional MRI).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent BOLD signal change in the MPFC</measure>
    <time_frame>immediately after the treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Smoking</condition>
  <condition>Addiction</condition>
  <arm_group>
    <arm_group_label>real treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous theta burst stimulation (real) will be delivered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>continuous theta burst stimulation (sham) will be delivered</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous theta burst stimulation (real)</intervention_name>
    <description>a form of transcranial magnetic stimulation that noninvasively induces a depression in brain reactivity</description>
    <arm_group_label>real treatment</arm_group_label>
    <other_name>cTBS (active)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous theta burst stimulation (sham)</intervention_name>
    <description>a sham version of a form of transcranial magnetic stimulation that noninvasively induces a depression in brain reactivity</description>
    <arm_group_label>sham treatment</arm_group_label>
    <other_name>cTBS (sham)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  smoke at least 10 cigarettes a day (on average)

        Exclusion Criteria:

          -  comorbid mental or physical illness (managed or unmanaged)

          -  pregnancy

          -  use of prescription medication that might affect smoking or nicotine metabolism,

          -  use of smokeless tobacco or alternative nicotine products

          -  use illicit drugs of abuse (verified through urine screen and self-report),

          -  score of above a 7 on the Alcohol Use Disorders Identification Test (indicative of
             non-risky use),

          -  a history of epilepsy or seizures not otherwise specified (other than childhood
             febrile seizures)

          -  a history of chronic migraines,

          -  failure to meet all criteria on a standardized MRI/TMS safety screen (including but
             not limited to implanted electronic devices, bullets or metallic fragments above the
             waist, hair clips and piercings above the waist that cannot be removed)

          -  presence of any barriers to making contact between the TMS coil and the skin (e.g.
             cornrows that cannot be removed, glasses that the participant is unwilling to remove).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colleen A Hanlon, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colleen A Hanlon, Ph.D.</last_name>
    <phone>(843)792-5732</phone>
    <email>hanlon@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Millie H Griffin, B.A.</last_name>
    <phone>(843) 792-2335</phone>
    <email>grifm@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen A Hanlon, Ph.D.</last_name>
      <phone>843-792-5732</phone>
      <email>hanlon@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep. 2011 Oct;13(5):398-405. doi: 10.1007/s11920-011-0224-0. Review.</citation>
    <PMID>21792580</PMID>
  </reference>
  <reference>
    <citation>Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005 Aug;162(8):1403-13. Review.</citation>
    <PMID>16055761</PMID>
  </reference>
  <reference>
    <citation>Sinha R, Catapano D, O'Malley S. Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl). 1999 Mar;142(4):343-51.</citation>
    <PMID>10229058</PMID>
  </reference>
  <reference>
    <citation>Lee JL, Milton AL, Everitt BJ. Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J Neurosci. 2006 May 31;26(22):5881-7.</citation>
    <PMID>16738229</PMID>
  </reference>
  <reference>
    <citation>Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol. 2012;52:321-36. doi: 10.1146/annurev-pharmtox-010611-134625. Epub 2011 Sep 27. Review.</citation>
    <PMID>21961707</PMID>
  </reference>
  <reference>
    <citation>Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci. 2004 Fall;16(4):456-64.</citation>
    <PMID>15616172</PMID>
  </reference>
  <reference>
    <citation>Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, Funderburk FR, Ernst M. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage. 2003 Jul;19(3):1085-94.</citation>
    <PMID>12880834</PMID>
  </reference>
  <reference>
    <citation>Hanlon CA, Wesley MJ, Stapleton JR, Laurienti PJ, Porrino LJ. The association between frontal-striatal connectivity and sensorimotor control in cocaine users. Drug Alcohol Depend. 2011 Jun 1;115(3):240-3. doi: 10.1016/j.drugalcdep.2010.11.008. Epub 2010 Dec 28.</citation>
    <PMID>21193273</PMID>
  </reference>
  <reference>
    <citation>Gu H, Salmeron BJ, Ross TJ, Geng X, Zhan W, Stein EA, Yang Y. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage. 2010 Nov 1;53(2):593-601. doi: 10.1016/j.neuroimage.2010.06.066. Epub 2010 Jul 11.</citation>
    <PMID>20603217</PMID>
  </reference>
  <reference>
    <citation>Bear MF, Malenka RC. Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol. 1994 Jun;4(3):389-99. Review.</citation>
    <PMID>7919934</PMID>
  </reference>
  <reference>
    <citation>Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004 Sep 30;44(1):5-21. Review.</citation>
    <PMID>15450156</PMID>
  </reference>
  <reference>
    <citation>Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6.</citation>
    <PMID>15664172</PMID>
  </reference>
  <reference>
    <citation>Di Lazzaro V, Pilato F, Saturno E, Oliviero A, Dileone M, Mazzone P, Insola A, Tonali PA, Ranieri F, Huang YZ, Rothwell JC. Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol. 2005 Jun 15;565(Pt 3):945-50. Epub 2005 Apr 21.</citation>
    <PMID>15845575</PMID>
  </reference>
  <reference>
    <citation>Verbruggen F, Aron AR, Stevens MA, Chambers CD. Theta burst stimulation dissociates attention and action updating in human inferior frontal cortex. Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13966-71. doi: 10.1073/pnas.1001957107. Epub 2010 Jul 14.</citation>
    <PMID>20631303</PMID>
  </reference>
  <reference>
    <citation>Cho SS, Ko JH, Pellecchia G, Van Eimeren T, Cilia R, Strafella AP. Continuous theta burst stimulation of right dorsolateral prefrontal cortex induces changes in impulsivity level. Brain Stimul. 2010 Jul;3(3):170-6. doi: 10.1016/j.brs.2009.10.002. Epub 2009 Oct 31.</citation>
    <PMID>20633446</PMID>
  </reference>
  <reference>
    <citation>Jacobson L, Javitt DC, Lavidor M. Activation of inhibition: diminishing impulsive behavior by direct current stimulation over the inferior frontal gyrus. J Cogn Neurosci. 2011 Nov;23(11):3380-7. doi: 10.1162/jocn_a_00020. Epub 2011 Mar 31.</citation>
    <PMID>21452949</PMID>
  </reference>
  <reference>
    <citation>Camprodon JA, Mart√≠nez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 2007 Jan 5;86(1):91-4. Epub 2006 Sep 12.</citation>
    <PMID>16971058</PMID>
  </reference>
  <reference>
    <citation>Politi E, Fauci E, Santoro A, Smeraldi E. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am J Addict. 2008 Jul-Aug;17(4):345-6. doi: 10.1080/10550490802139283.</citation>
    <PMID>18612892</PMID>
  </reference>
  <reference>
    <citation>Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr Drug Abuse Rev. 2008 Nov;1(3):328-39. Review.</citation>
    <PMID>19630729</PMID>
  </reference>
  <reference>
    <citation>Wing VC, Barr MS, Wass CE, Lipsman N, Lozano AM, Daskalakis ZJ, George TP. Brain stimulation methods to treat tobacco addiction. Brain Stimul. 2013 May;6(3):221-30. doi: 10.1016/j.brs.2012.06.008. Epub 2012 Jul 9. Review.</citation>
    <PMID>22809824</PMID>
  </reference>
  <reference>
    <citation>Hanlon CA, Canterberry M, Taylor JJ, DeVries W, Li X, Brown TR, George MS. Probing the frontostriatal loops involved in executive and limbic processing via interleaved TMS and functional MRI at two prefrontal locations: a pilot study. PLoS One. 2013 Jul 9;8(7):e67917. doi: 10.1371/journal.pone.0067917. Print 2013.</citation>
    <PMID>23874466</PMID>
  </reference>
  <reference>
    <citation>Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci. 2004 Apr;19(7):1950-62.</citation>
    <PMID>15078569</PMID>
  </reference>
  <reference>
    <citation>Bohning DE, Shastri A, Lomarev MP, Lorberbaum JP, Nahas Z, George MS. BOLD-fMRI response vs. transcranial magnetic stimulation (TMS) pulse-train length: testing for linearity. J Magn Reson Imaging. 2003 Mar;17(3):279-90.</citation>
    <PMID>12594717</PMID>
  </reference>
  <reference>
    <citation>Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 2012 Oct 1;72(7):595-603. doi: 10.1016/j.biopsych.2012.04.028. Epub 2012 Jun 1.</citation>
    <PMID>22658708</PMID>
  </reference>
  <reference>
    <citation>Vernet M, Bashir S, Yoo WK, Oberman L, Mizrahi I, Ifert-Miller F, Beck CJ, Pascual-Leone A. Reproducibility of the effects of theta burst stimulation on motor cortical plasticity in healthy participants. Clin Neurophysiol. 2014 Feb;125(2):320-6. doi: 10.1016/j.clinph.2013.07.004. Epub 2013 Aug 7.</citation>
    <PMID>23932365</PMID>
  </reference>
  <reference>
    <citation>Wilcox CE, Teshiba TM, Merideth F, Ling J, Mayer AR. Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders. Drug Alcohol Depend. 2011 May 1;115(1-2):137-44. doi: 10.1016/j.drugalcdep.2011.01.009. Epub 2011 Apr 3.</citation>
    <PMID>21466926</PMID>
  </reference>
  <reference>
    <citation>Prisciandaro JJ, McRae-Clark AL, Myrick H, Henderson S, Brady KT. Brain activation to cocaine cues and motivation/treatment status. Addict Biol. 2014 Mar;19(2):240-9. doi: 10.1111/j.1369-1600.2012.00446.x. Epub 2012 Mar 28.</citation>
    <PMID>22458561</PMID>
  </reference>
  <reference>
    <citation>Borckardt JJ, Nahas Z, Koola J, George MS. Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT. 2006 Sep;22(3):169-75.</citation>
    <PMID>16957531</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>October 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2016</study_first_posted>
  <last_update_submitted>June 7, 2017</last_update_submitted>
  <last_update_submitted_qc>June 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Colleen Hanlon</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

